SEO URLwww.firestrike.ai/deals/transcure-bioservices-taconic-acquisition-2026-1

acquisitionAnnounced · Jan 20, 2026preclinical research servicesSource · CredibleArticle · Factual

TransCure bioServices · Taconic

Taconic acquires TransCure bioServices

David Najork · Founding Software Engineer

Announced Jan 20, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

—

Target

TransCure bioServices

Archparc Le Forum 1 260 Av. Marie Curie, Archamps

Acquirer

Taconic

Full Acquisition

Status

Announced

Taconic agreed to acquire TransCure bioServices. Reported deal value: Undisclosed. Status: Announced. Sector: preclinical research services. Target headquarters context: Archparc Le Forum 1 260 Av. Marie Curie, Archamps, France.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

Taconic Biosciences , Inc. , a global leader in genetically engineered rodent models and humanized immune system mouse models, today announced the acquisition of TransCure bioServices SAS , a leading provider of preclinical research services utilizing HIS mouse models

Deal timeline

Announced

Jan 20, 2026 · businesswire.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in preclinical research services. Figures and status may change as sources update.

Sources: businesswire.com · Primary article · FireStrike proprietary index